CDT Equity CDT
NASDAQ CDT
$0.40 -0.04 (-9.09%)
At close: Nov 13, 2026 · 4:00 PM EST

CDT Equity (CDT) Non Operating Interest Expenses (2023 - 2024)

Updated

CDT Equity (CDT) posted Non Operating Interest Expenses of $309,000 for Q3 2024, up 557.4% from $47,000 a year earlier and up 159.7% from the prior quarter.

Analysis

CDT Equity (CDT) Non Operating Interest Expenses (2023 - 2024) Analysis & Trends

For the trailing twelve months through Sep 30, 2024, Non Operating Interest Expenses at CDT Equity was $594,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 217.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 CDT Equity 426.40 -6.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 309,000.00
Jun 30, 2024 119,000.00
Mar 31, 2024 119,000.00
Sep 30, 2023 47,000.00
API Access

CDT Equity Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CDT&period=max&api_key=YOUR_API_KEY